| Chemotherapy for advanced gastric cancer AD Wagner, NLX Syn, M Moehler, W Grothe, WP Yong, BC Tai, J Ho, ... Cochrane database of systematic reviews, 2017 | 1725 | 2017 |
| De-novo and acquired resistance to immune checkpoint targeting NL Syn, MWL Teng, TSK Mok, RA Soo The Lancet Oncology 18 (12), e731-e741, 2017 | 734 | 2017 |
| Exosome-mediated metastasis: from epithelial–mesenchymal transition to escape from immunosurveillance N Syn, L Wang, G Sethi, JP Thiery, BC Goh Trends in pharmacological sciences 37 (7), 606-617, 2016 | 478 | 2016 |
| Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges NL Syn, L Wang, EKH Chow, CT Lim, BC Goh Trends in biotechnology 35 (7), 665-676, 2017 | 357 | 2017 |
| Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled … NL Syn, DE Cummings, LZ Wang, DJ Lin, JJ Zhao, M Loh, ZJ Koh, ... The Lancet, 2021 | 299 | 2021 |
| Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies SM Lim, NL Syn, BC Cho, RA Soo Cancer treatment reviews 65, 1-10, 2018 | 251 | 2018 |
| Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: Current Controversies and Future Directions RA Soo, SM Lim, NL Syn, R Teng, R Soong, TSK Mok, BC Cho Lung Cancer, 2017 | 154 | 2017 |
| Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta … DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ... The Lancet Oncology 23 (4), 521-530, 2022 | 147 | 2022 |
| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell Metabolism 35 (3), 414-428. e3, 2023 | 134 | 2023 |
| Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview R Roudi, NL Syn, M Roudbary Frontiers in immunology 8, 305858, 2017 | 128 | 2017 |
| Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and propensity-score … NL Syn, T Kabir, YX Koh, HL Tan, LZ Wang, BZ Chin, I Wee, JY Teo, ... Annals of surgery 272 (2), 253-265, 2020 | 121 | 2020 |
| Global attitudes in the management of acute appendicitis during COVID-19 pandemic: ACIE Appy Study B Ielpo, M Podda, G Pellino, F Pata, R Caruso, G Gravante, S Di Saverio, ... British Journal of Surgery, 2020 | 118 | 2020 |
| Gut microbiota changes in children with autism spectrum disorder: a systematic review LKH Ho, VJW Tong, N Syn, N Nagarajan, EH Tham, SK Tay, S Shorey, ... Gut Pathogens 12 (1), 6, 2020 | 111 | 2020 |
| Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma JJ Zhao, DWT Yap, YH Chan, BKJ Tan, CB Teo, NL Syn, EC Smyth, ... Journal of Clinical Oncology, JCO. 21.01862, 2021 | 99 | 2021 |
| Role of tumor-derived exosomes in cancer metastasis I Wee, N Syn, G Sethi, BC Goh, L Wang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (1), 12-19, 2019 | 94 | 2019 |
| Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome: A Randomized Clinical Trial YS Yap, LL Kwok, N Syn, WY Chay, JWK Chia, CK Tham, NS Wong, ... JAMA Oncology, 2017 | 90 | 2017 |
| Enhanced recovery versus conventional care in gastric cancer surgery: a meta-analysis of randomized and non-randomized controlled trials IJY Wee, NLX Syn, A Shabbir, G Kim, JBY So Gastric Cancer 22, 423-434, 2019 | 85 | 2019 |
| Learning curves in minimally invasive hepatectomy: systematic review and meta-regression analysis D Chua, N Syn, YX Koh, BKP Goh British Journal of Surgery 108 (4), 351-358, 2021 | 76 | 2021 |
| Learning curve of laparoscopic and robotic pancreas resections: a systematic review KS Chan, ZK Wang, N Syn, BKP Goh Surgery 170 (1), 194-206, 2021 | 75 | 2021 |
| Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling L Wang, NLX Syn, VV Subhash, Y Any, WL Thuya, E Cheow, L Kong, ... Cancer Letters, 2018 | 69 | 2018 |
